Valeant Pharmaceuticals International, Inc. (TSE:VRX – Get Free Report) (NYSE:VRX) shares dropped 3.3% during mid-day trading on Monday . The stock traded as low as C$30.75 and last traded at C$30.80. Approximately 1,232,408 shares were traded during mid-day trading, a decline of 11% from the average daily volume of 1,382,994 shares. The stock had previously closed at C$31.86.
Valeant Pharmaceuticals International Price Performance
The business’s 50 day simple moving average is C$30.80.
About Valeant Pharmaceuticals International
Valeant Pharmaceuticals International, Inc operates as a multinational, specialty pharmaceutical, and medical device company that develops, manufactures, and markets a range of pharmaceuticals, over-the-counter (OTC) products, and medical devices. The company operates through three segments: Bausch + Lomb/International, Branded Rx, and U.S.
Featured Stories
- Five stocks we like better than Valeant Pharmaceuticals International
- 3 Warren Buffett Stocks to Buy Now
- Intel: Is Now the Time to Be Brave?Â
- 5 Top Rated Dividend Stocks to Consider
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- 3 Monster Growth Stocks to Buy Now
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Valeant Pharmaceuticals International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeant Pharmaceuticals International and related companies with MarketBeat.com's FREE daily email newsletter.
